Cargando…

Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease

BACKGROUND: In Alzheimer’s disease (AD), fibrillar tau initially occurs locally and progresses preferentially between closely connected regions. However, the underlying sources of regional vulnerability to tau pathology remain unclear. Previous brain-autopsy findings suggest that the myelin levels—w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubinski, Anna, Franzmeier, Nicolai, Dewenter, Anna, Luan, Ying, Smith, Ruben, Strandberg, Olof, Ossenkoppele, Rik, Dichgans, Martin, Hansson, Oskar, Ewers, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508747/
https://www.ncbi.nlm.nih.gov/pubmed/36153607
http://dx.doi.org/10.1186/s13195-022-01074-9
_version_ 1784797084253159424
author Rubinski, Anna
Franzmeier, Nicolai
Dewenter, Anna
Luan, Ying
Smith, Ruben
Strandberg, Olof
Ossenkoppele, Rik
Dichgans, Martin
Hansson, Oskar
Ewers, Michael
author_facet Rubinski, Anna
Franzmeier, Nicolai
Dewenter, Anna
Luan, Ying
Smith, Ruben
Strandberg, Olof
Ossenkoppele, Rik
Dichgans, Martin
Hansson, Oskar
Ewers, Michael
author_sort Rubinski, Anna
collection PubMed
description BACKGROUND: In Alzheimer’s disease (AD), fibrillar tau initially occurs locally and progresses preferentially between closely connected regions. However, the underlying sources of regional vulnerability to tau pathology remain unclear. Previous brain-autopsy findings suggest that the myelin levels—which differ substantially between white matter tracts in the brain—are a key modulating factor of region-specific susceptibility to tau deposition. Here, we investigated whether myelination differences between fiber tracts of the human connectome are predictive of the interregional spreading of tau pathology in AD. METHODS: We included two independently recruited samples consisting of amyloid-PET-positive asymptomatic and symptomatic elderly individuals, in whom tau-PET was obtained at baseline (ADNI: n = 275; BioFINDER-1: n = 102) and longitudinally in a subset (ADNI: n = 123, mean FU = 1.53 [0.69–3.95] years; BioFINDER-1: n = 39, mean FU = 1.87 [1.21–2.78] years). We constructed MRI templates of the myelin water fraction (MWF) in 200 gray matter ROIs and connecting fiber tracts obtained from adult cognitively normal participants. Using the same 200 ROI brain-parcellation atlas, we obtained tau-PET ROI values from each individual in ADNI and BioFINDER-1. In a spatial regression analysis, we first tested the association between cortical myelin and group-average tau-PET signal in the amyloid-positive and control groups. Secondly, employing a previously established approach of modeling tau-PET spreading based on functional connectivity between ROIs, we estimated in a linear regression analysis, whether the level of fiber-tract myelin modulates the association between functional connectivity and longitudinal tau-PET spreading (i.e., covariance) between ROIs. RESULTS: We found that higher myelinated cortical regions show lower tau-PET uptake (ADNI: rho =  − 0.267, p < 0.001; BioFINDER-1: rho =  − 0.175, p = 0.013). Fiber-tract myelin levels modulated the association between functional connectivity and tau-PET spreading, such that at higher levels of fiber-tract myelin, the association between stronger connectivity and higher covariance of tau-PET between the connected ROIs was attenuated (interaction fiber-tract myelin × functional connectivity: ADNI: β =  − 0.185, p < 0.001; BioFINDER-1: β =  − 0.166, p < 0.001). CONCLUSION: Higher levels of myelin are associated with lower susceptibility of the connected regions to accumulate fibrillar tau. These results enhance our understanding of brain substrates that explain regional variation in tau accumulation and encourage future studies to investigate potential underlying mechanisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01074-9.
format Online
Article
Text
id pubmed-9508747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95087472022-09-25 Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease Rubinski, Anna Franzmeier, Nicolai Dewenter, Anna Luan, Ying Smith, Ruben Strandberg, Olof Ossenkoppele, Rik Dichgans, Martin Hansson, Oskar Ewers, Michael Alzheimers Res Ther Research BACKGROUND: In Alzheimer’s disease (AD), fibrillar tau initially occurs locally and progresses preferentially between closely connected regions. However, the underlying sources of regional vulnerability to tau pathology remain unclear. Previous brain-autopsy findings suggest that the myelin levels—which differ substantially between white matter tracts in the brain—are a key modulating factor of region-specific susceptibility to tau deposition. Here, we investigated whether myelination differences between fiber tracts of the human connectome are predictive of the interregional spreading of tau pathology in AD. METHODS: We included two independently recruited samples consisting of amyloid-PET-positive asymptomatic and symptomatic elderly individuals, in whom tau-PET was obtained at baseline (ADNI: n = 275; BioFINDER-1: n = 102) and longitudinally in a subset (ADNI: n = 123, mean FU = 1.53 [0.69–3.95] years; BioFINDER-1: n = 39, mean FU = 1.87 [1.21–2.78] years). We constructed MRI templates of the myelin water fraction (MWF) in 200 gray matter ROIs and connecting fiber tracts obtained from adult cognitively normal participants. Using the same 200 ROI brain-parcellation atlas, we obtained tau-PET ROI values from each individual in ADNI and BioFINDER-1. In a spatial regression analysis, we first tested the association between cortical myelin and group-average tau-PET signal in the amyloid-positive and control groups. Secondly, employing a previously established approach of modeling tau-PET spreading based on functional connectivity between ROIs, we estimated in a linear regression analysis, whether the level of fiber-tract myelin modulates the association between functional connectivity and longitudinal tau-PET spreading (i.e., covariance) between ROIs. RESULTS: We found that higher myelinated cortical regions show lower tau-PET uptake (ADNI: rho =  − 0.267, p < 0.001; BioFINDER-1: rho =  − 0.175, p = 0.013). Fiber-tract myelin levels modulated the association between functional connectivity and tau-PET spreading, such that at higher levels of fiber-tract myelin, the association between stronger connectivity and higher covariance of tau-PET between the connected ROIs was attenuated (interaction fiber-tract myelin × functional connectivity: ADNI: β =  − 0.185, p < 0.001; BioFINDER-1: β =  − 0.166, p < 0.001). CONCLUSION: Higher levels of myelin are associated with lower susceptibility of the connected regions to accumulate fibrillar tau. These results enhance our understanding of brain substrates that explain regional variation in tau accumulation and encourage future studies to investigate potential underlying mechanisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01074-9. BioMed Central 2022-09-24 /pmc/articles/PMC9508747/ /pubmed/36153607 http://dx.doi.org/10.1186/s13195-022-01074-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rubinski, Anna
Franzmeier, Nicolai
Dewenter, Anna
Luan, Ying
Smith, Ruben
Strandberg, Olof
Ossenkoppele, Rik
Dichgans, Martin
Hansson, Oskar
Ewers, Michael
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
title Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
title_full Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
title_fullStr Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
title_full_unstemmed Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
title_short Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
title_sort higher levels of myelin are associated with higher resistance against tau pathology in alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508747/
https://www.ncbi.nlm.nih.gov/pubmed/36153607
http://dx.doi.org/10.1186/s13195-022-01074-9
work_keys_str_mv AT rubinskianna higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT franzmeiernicolai higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT dewenteranna higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT luanying higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT smithruben higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT strandbergolof higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT ossenkoppelerik higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT dichgansmartin higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT hanssonoskar higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT ewersmichael higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease
AT higherlevelsofmyelinareassociatedwithhigherresistanceagainsttaupathologyinalzheimersdisease